GlassScriptPhysician profile
Guensley Delva
NPI 1285019018
$37,092.93
in general payments reported to CMS, 2019-2025
22 companies · $10K in 2025
The $10K reported for 2025 was more than what 94% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $554 · 2021: $3,841 · 2022: $6,929 · 2023: $9,703 · 2024: $5,958 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $13,880.78 |
| Food and Beverage | $11,887.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,282.10 | 2020-2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Medtronic, INC. | $6,709.10 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Abbott Laboratories | $2,775.20 | 2023-2025 | Proclaim, Eterna, Durata |
| Saluda Medical Americas, INC. | $2,622.55 | 2023-2024 | Evoke, Evoke Scs |
| Painteq LLC | $2,601.89 | 2021-2024 | Painteq |
| Relievant Medsystems, INC. | $2,403.81 | 2021-2023 | Intracept |
| Nalu Medical, INC. | $2,163.32 | 2021-2024 | Nalu Neurostimulation System |
| Nevro Corp. | $1,975.77 | 2020-2024 | Senza |
| Spinal Simplicity, LLC | $1,863.86 | 2022-2025 | Ha Minuteman G3-R |
| Si-Bone, INC. | $1,254.07 | 2024-2025 | |
| Spr Therapeutics, INC | $1,038.89 | 2022-2025 | Sprint Pns System |
| Curonix LLC | $821.76 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $685.33 | 2020-2022 | |
| Vertos Medical, INC. | $298.16 | 2021-2024 | Mild Device Kit |
| Stryker Corporation | $175.00 | 2025 | Mild Device Kit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $163.83 | 2023 | Reactiv8 |
| Grt US Holding, INC. | $108.10 | 2022 | |
| Forte Bio-Pharma LLC | $44.54 | 2021-2024 | Prolate, Nalocet |
| Collegium Pharmaceutical, INC. | $35.00 | 2022-2023 | Xtampza |
| Globus Medical, INC. | $34.05 | 2025 | Senza |
| Medtronic USA, INC. | $21.74 | 2020 | |
| Convatec INC. | $14.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guensley Delva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.